Biological analysis of the single codon deletion in Exon 19 of EGF receptor in non-small cell lung cancer responsive to gefitinib Source: Annual Congress 2009 - Epidemiology and management of lung cancer Year: 2009
The association between microsatellite polymorphism in intron II of human toll-like receptor 2 and tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 466s Year: 2004
Evaluation of EGFR mutations and ERCC2 polymorphisms in treatment of non-small cell lung cancer Source: Annual Congress 2005 - Chemotherapy and palliative care Year: 2005
Diagnostic utility of PNA-LNA PCR clamp method for detection of EGFR exon 19 deletions and exon 21 codon L858 mutations in NSCLC samples with low tumor cells content Source: Annual Congress 2012 - New results in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease Year: 2012
Germ-line exon 21 EGFR mutations, V843I and P848L, in nonsmall cell lung cancer patients Source: Eur Respir Rev 2014; 23: 390-392 Year: 2014
Relationship of human papillomaviruses and codon 72 polymorphism in the TP53 gene with lung cancer in north of Iran Source: Eur Respir J 2007; 30: Suppl. 51, 132s Year: 2007
Gefitinib as first-line treatment for patients with NSCLC with activating EGFR mutationin exons 19 (Del19) or 21 (L858R) in the Czech Republic Source: International Congress 2015 – Lung cancer therapy: clinical trials Year: 2015
Frequency of T790M substitution in exon 20 of EGFR gene in brain metastases in chemotherapy-naive non-small cell lung cancer patients (NSCLC) Source: Annual Congress 2012 - New results in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease Year: 2012
Arg72Pro P53 gene polymorphism is associated with P53 mutations in non-small cell lung cancer (NSCLC) patients Source: Eur Respir J 2004; 24: Suppl. 48, 78s Year: 2004
Investigation of a relationship between NF-KB1A gene polymorphism and non small cell lung cancer (NSCLC) Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012
Association of -93G®A polymorphism in the hMLH1 gene with susceptibility to and prognosis of non-small cell lung cancer in Taiwan Source: Eur Respir J 2006; 28: Suppl. 50, 151s Year: 2006
The influence of the polymorphism at codon 72 of exon 4 of the P53 gene and GSTM1 and GSTT1 null in lung cancer risk in a Brazilian population Source: Eur Respir J 2006; 28: Suppl. 50, 812s Year: 2006
Arg72Pro P53 gene polymorphism as a predisposing factor for non-small cell lung cancer (NSCLC) development Source: Eur Respir J 2004; 24: Suppl. 48, 78s Year: 2004
Frequency and clinical-tomographic characterization of NSCLC with T790M mutation to TKI progression. Source: International Congress 2019 – Diagnosis of lung cancer Year: 2019
LSC Abstract – Association of single nucleotide polymorphisms located in miRNA binding sites with lung function Source: International Congress 2016 – New signalling pathways in COPD Year: 2016
Exon 22 A3650G, Intron 27 T520C and Exon 33 C5507G polymorphisms of complement receptor 1 gene are associated with idiopathic pulmonary fibrosis Source: Annual Congress 2003 - Immunology of interstitial lung diseases Year: 2003
Polymorphisms in the interleukin-10 gene promoter are associated with susceptibility to non-small cell lung cancer (NSCLC) Source: Eur Respir J 2005; 26: Suppl. 49, 458s Year: 2005
Equal efficacy of gefitinib in chemonaive lung adenocarcinoma patients with either exon 19 deletion or L858R point mutation Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016
Very early detection of small clones harbouring EGFR mutations in NSCLC by 2nd generation sequencing Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics Year: 2011
The allelic frequency for S and Z mutations in the SERPINA1 gene in NSCLC patients from Poland Source: International Congress 2017 – Gene signatures in bronchial diseases Year: 2017